
### [NCIT:C5136](http://purl.obolibrary.org/obo/NCIT_C5136)
**Label:** Childhood Glioblastoma

**Subclasses:** [NCIT:C114966](http://purl.obolibrary.org/obo/NCIT_C114966) (Childhood Giant Cell Glioblastoma), [NCIT:C115365](http://purl.obolibrary.org/obo/NCIT_C115365) (Recurrent Childhood Gliosarcoma), [NCIT:C115364](http://purl.obolibrary.org/obo/NCIT_C115364) (Recurrent Childhood Glioblastoma), [NCIT:C115363](http://purl.obolibrary.org/obo/NCIT_C115363) (Recurrent Childhood Giant Cell Glioblastoma), [NCIT:C114759](http://purl.obolibrary.org/obo/NCIT_C114759) (Childhood Brain Stem Gliosarcoma), [NCIT:C114968](http://purl.obolibrary.org/obo/NCIT_C114968) (Childhood Gliosarcoma), 

**Class expressions from DL-Learner:**

- Thing 54.60%
- [NCIT:C28082](http://purl.obolibrary.org/obo/NCIT_C28082) (Grade 4) 51.52%
- [NCIT:C14158](http://purl.obolibrary.org/obo/NCIT_C14158) (High Grade) 51.52%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C14161](http://purl.obolibrary.org/obo/NCIT_C14161) (Low Grade))) 51.52%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) 36.87%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39909](http://purl.obolibrary.org/obo/NCIT_C39909) (Gain of Chromosome 18q))) 36.87%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39907](http://purl.obolibrary.org/obo/NCIT_C39907) (Seminal Vesicle Cystadenoma))) 36.87%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39906](http://purl.obolibrary.org/obo/NCIT_C39906) (Seminal Vesicle Adenocarcinoma))) 36.87%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39905](http://purl.obolibrary.org/obo/NCIT_C39905) (Prostate Stromal Proliferation of Uncertain Malignant Potential))) 36.87%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation))) 36.87%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma))) 36.87%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 36.87%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma))) 36.87%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern))) 36.87%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern))) 36.87%


